|
|
Home
|
University showcases medical advances |
|
|
|
Wednesday, 20 June 2007 |
An exhibition showcasing new drug discoveries, including technology to prevent MRSA infection, an oral vaccine to replace injections and a marigold-based treatment for psoriasis, will open today in Glasgow.
The research, developed by scientists at the University of Strathclyde’s Institute of Pharmacy and Biomedical Sciences, includes a new method of controlling bacterial infections such as MRSA by embedding bacteriophages – naturally occurring viruses that prey on bacteria - into physical materials, such as cotton, silk and polythene, to prevent the ‘superbug’ infection.
Other discoveries include a new treatment for the skin condition psoriasis, which affects around three percent of the population in Europe and North America, and a drinkable influenza vaccine, which could replace the traditional injection.
Anne Muir, business development manager at the Faculty of Science, said: "The Institute is working on leading-edge research and technology to tackle the diseases of the 21st Century. We are delighted to be welcoming representatives from companies across the UK to view our developments.
"Strathclyde has a proud record of drug discovery and development. We are committed to working closely with industry to help ensure our research is translated into products that benefit patients."
No one has commented on this article.
Related news items:
|
|
Last Updated ( Wednesday, 20 June 2007 )
|
Featured sites
Maggie's - cancer caring centres
Maggie's Centres are for anybody who has, or who has had cancer. They are also for their families, their friends and their carers.
The aim of Maggie's Centres is to help people with cancer to be as healthy in mind and body as possible and enable them to make their own contribution to their medical treatment and recovery.
Click here to visit this site
Site news...
Have your say: We have introduced a comments system in our news and magazine article sections, submit your comments for approval. Your comments will feature in the "Your comments" section.
|
|
|
